Crossmark

Economic evaluation of ceftazidime-avibactam vs. polymyxin B for treatment of hospital-acquired and ventilator-associated bacterial pneumonia

Crossref DOI link: https://doi.org/10.1016/j.bjid.2025.104545

Published Print: 2025-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Matuoka, Jessica https://orcid.org/0000-0002-7956-1606
Pachito, Daniela Vianna https://orcid.org/0000-0002-7052-7735
Piastrelli, Filipe https://orcid.org/0000-0002-7278-783X
Fehlberg, Lorena Cristina Correa

de Oliveira Junior, Haliton Alves https://orcid.org/0000-0002-0289-4947
License Information

Text and Data Mining valid from 2025-07-01

Text and Data Mining valid from 2025-07-01

Version of Record valid from 2025-05-09
More Information

This article is maintained by: Elsevier

Article Title: Economic evaluation of ceftazidime-avibactam vs. polymyxin B for treatment of hospital-acquired and ventilator-associated bacterial pneumonia

Journal Title: The Brazilian Journal of Infectious Diseases

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.bjid.2025.104545

Content Type: article

Copyright: © 2025 Sociedade Brasileira de Infectologia. Published by Elsevier España, S.L.U.